April 2, 2018 / 8:23 PM / 6 months ago

BRIEF-Spero Therapeutics Posts Qtrly Loss Of $1.59 Per Share

April 2 (Reuters) - Spero Therapeutics Inc:

* SPERO THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 OPERATING RESULTS AND PROVIDES PIPELINE UPDATE

* QTRLY LOSS PER SHARE $1.59

* EXPECTS THAT ITS RESEARCH AND DEVELOPMENT EXPENSES WILL INCREASE THROUGHOUT 2018

* BELIEVES EXISTING CASH AND CASH EQUIVALENTS WILL FUND OPERATING EXPENSES & CAPITAL EXPENDITURE REQUIREMENTS INTO Q2 2019

* AS OF DEC 31, 2017, CO HAD CASH AND CASH EQUIVALENTS OF $87.3 MILLION Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below